Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed
- PMID: 31551578
- DOI: 10.1038/s41591-019-0603-3
Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed
Erratum in
-
Author Correction: Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed.Nat Med. 2019 Dec;25(12):1948. doi: 10.1038/s41591-019-0662-5. Nat Med. 2019. PMID: 31719666
References
-
- US Food and Drug Administration. Artificial Intelligence and Machine Learning in Software as a Medical Device (accessed 18 September 2019). https://www.fda.gov/medical-devices/software-medical-device-samd/artific...
-
- Chalmers, I., Glasziou, P., Heneghan, C., Shepperd, S., Loudon, K. & Bossuyt, P. M. Avoidable waste in the production and reporting of research evidence. Lancet 374, 86–89 (2009). - DOI
-
- Schulz, K. F., Altman, D. G. & Moher, D., for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int. J. Surg. 9, 672–677 (2011). - DOI
-
- Chan, A. W., Tetzlaff, J. M., Altman, D. G., Dickersin, K. & Moher, D. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet 381, 91–92 (2013). - DOI
-
- EQUATOR Network. Reporting guidelines under development (EQUATOR Network, accessed 4 August 2019); http://www.equator-network.org/library/reporting-guidelines-under-develo...
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
